C E Fasching

696 total citations
22 papers, 575 citations indexed

About

C E Fasching is a scholar working on Pharmacology, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, C E Fasching has authored 22 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 6 papers in Epidemiology and 5 papers in Clinical Biochemistry. Recurrent topics in C E Fasching's work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Antibiotic Resistance in Bacteria (5 papers) and Bacterial Identification and Susceptibility Testing (5 papers). C E Fasching is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (11 papers), Antibiotic Resistance in Bacteria (5 papers) and Bacterial Identification and Susceptibility Testing (5 papers). C E Fasching collaborates with scholars based in United States. C E Fasching's co-authors include Lance R. Peterson, Dale N. Gerding, Lance R. Peterson, Karen Willard‐Gallo, Joseph J. Goswitz, Edward N. Janoff, L L Van Etta, Jeffrey B. Rubins, Julia Moody and Darlene Charboneau and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

C E Fasching

22 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C E Fasching United States 14 225 195 181 125 103 22 575
J. P. Maskell United Kingdom 17 150 0.7× 263 1.3× 174 1.0× 195 1.6× 145 1.4× 35 705
P. Van der Auwera Belgium 15 260 1.2× 260 1.3× 151 0.8× 209 1.7× 88 0.9× 41 713
Anand P. Panwalker United States 13 168 0.7× 257 1.3× 129 0.7× 189 1.5× 69 0.7× 27 651
Christine Warren United Kingdom 19 269 1.2× 191 1.0× 226 1.2× 140 1.1× 269 2.6× 36 927
Barbara G. Painter United States 14 292 1.3× 253 1.3× 197 1.1× 229 1.8× 109 1.1× 24 800
J. A. Faiella United States 8 208 0.9× 227 1.2× 161 0.9× 146 1.2× 75 0.7× 8 529
A Kazmierczak France 13 179 0.8× 206 1.1× 230 1.3× 134 1.1× 43 0.4× 47 477
A. Featherstone United Kingdom 11 267 1.2× 191 1.0× 136 0.8× 116 0.9× 44 0.4× 17 575
G Ravizzola Italy 13 103 0.5× 207 1.1× 173 1.0× 90 0.7× 68 0.7× 36 523
E Vallée France 16 307 1.4× 419 2.1× 266 1.5× 157 1.3× 59 0.6× 31 642

Countries citing papers authored by C E Fasching

Since Specialization
Citations

This map shows the geographic impact of C E Fasching's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C E Fasching with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C E Fasching more than expected).

Fields of papers citing papers by C E Fasching

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C E Fasching. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C E Fasching. The network helps show where C E Fasching may publish in the future.

Co-authorship network of co-authors of C E Fasching

This figure shows the co-authorship network connecting the top 25 collaborators of C E Fasching. A scholar is included among the top collaborators of C E Fasching based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C E Fasching. C E Fasching is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Janoff, Edward N., Jeffrey B. Rubins, C E Fasching, et al.. (2013). Pneumococcal IgA1 protease subverts specific protection by human IgA1. Mucosal Immunology. 7(2). 249–256. 65 indexed citations
2.
Johnson, et al.. (2002). Novel Molecular Variants of Allele I of the P Fimbrial Adhesin Gene.. 70(5). 2739–2739. 1 indexed citations
3.
Johnson, James R., Adam L. Stell, Flemming Scheutz, et al.. (2000). Analysis of the F Antigen-Specific papA Alleles of Extraintestinal Pathogenic Escherichia coli Using a Novel Multiplex PCR-Based Assay. Infection and Immunity. 68(12). 7215–7215. 21 indexed citations
4.
Williams, David N., C E Fasching, & Edward N. Janoff. (1998). Septic Siblings with Pneumonia Due to Penicillin-Resistant Streptococcus pneumoniae. Clinical Infectious Diseases. 26(5). 1230–1231. 2 indexed citations
5.
Rubins, Jeffrey B., Darlene Charboneau, C E Fasching, et al.. (1996). Distinct Roles for Pneumolysin's Cytotoxic and Complement Activities in the Pathogenesis of Pneumococcal Pneumonia. American Journal of Respiratory and Critical Care Medicine. 153(4). 1339–1346. 82 indexed citations
6.
Goswitz, Joseph J., Karen Willard‐Gallo, C E Fasching, & Lance R. Peterson. (1992). Detection of gyrA gene mutations associated with ciprofloxacin resistance in methicillin-resistant Staphylococcus aureus: analysis by polymerase chain reaction and automated direct DNA sequencing. Antimicrobial Agents and Chemotherapy. 36(5). 1166–1169. 95 indexed citations
7.
Fasching, C E, Fred C. Tenover, Thomas G. Slama, et al.. (1991). gyrA Mutations in Ciprofloxacin-Resistant, Methicillin-Resistant Staphylococcus aureus from Indiana, Minnesota, and Tennessee. The Journal of Infectious Diseases. 164(5). 976–979. 31 indexed citations
8.
Moody, Julia, et al.. (1990). Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.. PubMed. 115(2). 190–5. 8 indexed citations
9.
Peterson, Lance R., Julia Moody, C E Fasching, & Dale N. Gerding. (1989). Influence of protein binding on therapeutic efficacy of cefoperazone. Antimicrobial Agents and Chemotherapy. 33(4). 566–568. 16 indexed citations
10.
Fasching, C E, Dale N. Gerding, & Lance R. Peterson. (1987). Treatment of ciprofloxacin- and ceftizoxime-induced resistant gram-negative bacilli.. PubMed. 82(4A). 80–6. 4 indexed citations
11.
Gerding, D. N., Lance R. Peterson, Julia Moody, & C E Fasching. (1985). Mezlocillin, ceftizoxime, and amikacin alone and in combination against six Enterobacteriaceae in a nentropenic site in rabbits. Journal of Antimicrobial Chemotherapy. 15(suppl A). 207–219. 12 indexed citations
12.
Peterson, Lance R., et al.. (1984). Ciprofloxacin penetration into extravascular spaces in a rabbit model. Antimicrobial Agents and Chemotherapy. 26(6). 935–936. 5 indexed citations
13.
Peterson, Lance R., L L Van Etta, C E Fasching, & Dale N. Gerding. (1984). Effect of protein binding on simulated intravascular and extravascular kinetics of cefotaxime in an in vitro model. Antimicrobial Agents and Chemotherapy. 25(1). 58–61. 10 indexed citations
14.
Fasching, C E, Carolyn E. Hughes, R F Hector, & Lance R. Peterson. (1984). High-pressure liquid chromatographic assay of Bay n 7133 in human serum. Antimicrobial Agents and Chemotherapy. 25(5). 596–598. 2 indexed citations
15.
Peterson, Lance R., Dale N. Gerding, Julia Moody, & C E Fasching. (1984). Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model. Antimicrobial Agents and Chemotherapy. 25(5). 545–552. 25 indexed citations
16.
Fasching, C E & Lance R. Peterson. (1982). Anion-exchange extraction of cephapirin, cefotaxime, and cefoxitin from serum for liquid chromatography. Antimicrobial Agents and Chemotherapy. 21(4). 628–633. 29 indexed citations
17.
Fasching, C E, et al.. (1982). High-pressure liquid chromatographic assay of ceftizoxime with an anion-exchange extraction technique. Antimicrobial Agents and Chemotherapy. 22(2). 336–337. 19 indexed citations
18.
Etta, L L Van, et al.. (1982). Effect of method of administration on extravascular penetration of four antibiotics. Antimicrobial Agents and Chemotherapy. 21(6). 873–880. 23 indexed citations
19.
Etta, L L Van, Lance R. Peterson, C E Fasching, & Dale N. Gerding. (1982). Effect of the Ratio of Surface Area to Volume on the Penetration of Antibiotics into Extravascular Spaces in an in Vitro Model. The Journal of Infectious Diseases. 146(3). 423–428. 63 indexed citations
20.
Peterson, Lance R., et al.. (1981). Pharmacokinetics, protein binding, and predicted extravascular distribution of moxalactam in normal and renal failure subjects. Antimicrobial Agents and Chemotherapy. 20(3). 378–381. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026